6.47
price up icon1.73%   0.11
after-market 시간 외 거래: 6.50 0.03 +0.46%
loading
전일 마감가:
$6.36
열려 있는:
$6.42
하루 거래량:
1.35M
Relative Volume:
1.04
시가총액:
$560.14M
수익:
-
순이익/손실:
$-168.09M
주가수익비율:
-2.9816
EPS:
-2.17
순현금흐름:
$-138.01M
1주 성능:
+1.89%
1개월 성능:
+10.60%
6개월 성능:
-12.45%
1년 성능:
-69.12%
1일 변동 폭
Value
$6.38
$6.61
1주일 범위
Value
$6.08
$6.695
52주 변동 폭
Value
$5.41
$21.60

Kura Oncology Inc Stock (KURA) Company Profile

Name
명칭
Kura Oncology Inc
Name
전화
(858) 500-8800
Name
주소
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Name
직원
192
Name
트위터
@kuraoncology
Name
다음 수익 날짜
2025-02-21
Name
최신 SEC 제출 서류
Name
KURA's Discussions on Twitter

KURA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KURA
Kura Oncology Inc
6.47 549.75M 0 -168.09M -138.01M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-06 다운그레이드 BTIG Research Buy → Neutral
2024-10-24 개시 UBS Buy
2024-10-14 다운그레이드 Stifel Buy → Hold
2023-12-22 개시 Mizuho Buy
2023-08-11 개시 BofA Securities Buy
2023-07-27 개시 Scotiabank Sector Perform
2023-05-17 개시 BTIG Research Buy
2023-01-31 개시 Stifel Buy
2022-07-12 개시 Cantor Fitzgerald Overweight
2022-02-15 개시 Jefferies Buy
2021-05-05 재개 Credit Suisse Outperform
2021-04-26 재개 Credit Suisse Outperform
2020-12-07 재확인 H.C. Wainwright Buy
2020-12-03 개시 Stifel Buy
2020-11-05 다운그레이드 Piper Sandler Overweight → Neutral
2020-07-07 개시 Credit Suisse Outperform
2020-05-05 개시 Barclays Overweight
2019-07-18 개시 Deutsche Bank Buy
2018-11-09 개시 Piper Jaffray Overweight
2018-08-01 개시 H.C. Wainwright Buy
2016-10-13 재개 Leerink Partners Outperform
2016-01-22 개시 JMP Securities Mkt Outperform
2015-12-30 개시 Oppenheimer Outperform
2015-12-16 개시 Citigroup Buy
모두보기

Kura Oncology Inc 주식(KURA)의 최신 뉴스

pulisher
03:21 AM

What drives Kura Oncology Inc. stock priceOutstanding yields - Autocar Professional

03:21 AM
pulisher
Jul 19, 2025

What analysts say about Kura Oncology Inc. stockSignificant capital appreciation - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

Is Kura Oncology Inc. a good long term investmentExplosive portfolio gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

Kura Oncology Inc. Stock Analysis and ForecastDouble-digit growth - Jammu Links News

Jul 18, 2025
pulisher
Jul 16, 2025

Why Kura Oncology Inc. stock attracts strong analyst attentionFree AI-Driven Trading Strategies - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

How Kura Oncology Inc. stock performs during market volatilityFree Access to Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Kura Oncology Inc. stock price move sharplyHigh Reward Risk Balanced Trading - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Health Check: How Prudently Does Kura Oncology (NASDAQ:KURA) Use Debt? - simplywall.st

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Takes $139,000 Position in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jul 10, 2025
pulisher
Jul 03, 2025

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 03, 2025
pulisher
Jul 03, 2025

Kura Oncology shares rise 3.34% after-hours following inducement grants to new employees. - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

Kura Oncology's Ziftomenib: A Near-Term FDA Catalyst and a Paradigm Shift for AML Patients - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Kura Oncology Partners with Kyowa Kirin for Ziftomenib - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US By Investing.com - Investing.com South Africa

Jul 01, 2025
pulisher
Jun 29, 2025

Kura Oncology, Inc.(NasdaqGS: KURA) added to Russell 3000E Value Index - MarketScreener

Jun 29, 2025
pulisher
Jun 27, 2025

Kura Oncology (NASDAQ:KURA) Given Overweight Rating at Cantor Fitzgerald - Defense World

Jun 27, 2025
pulisher
Jun 26, 2025

KURA: Cantor Fitzgerald Reiterates Overweight Rating | KURA Stoc - GuruFocus

Jun 26, 2025
pulisher
Jun 22, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Rhumbline Advisers - Defense World

Jun 22, 2025
pulisher
Jun 20, 2025

KURA: Wedbush Reiterates 'Outperform' Rating with $36 Price Target | KURA Stock News - GuruFocus

Jun 20, 2025
pulisher
Jun 18, 2025

Transcript : Kura Oncology, Inc.Special Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Kura Oncology Announces Positive Phase 1a/1b Trial Results - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (KURA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Kura Oncology rises after new early-stage trial data for leukemia therapy - MSN

Jun 17, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Invests $66,000 in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook - Investing.com Australia

Jun 14, 2025
pulisher
Jun 13, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlook By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 12, 2025

KURA's Ziftomenib Shows Promising Results in AML Clinical Trial - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Is the Options Market Predicting a Spike in Kura Oncology Stock? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology (KURA) Shows Promising Results for AML Therapy - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology Says Ziftomenib Study Achieves Complete Remission in Acute Myeloid Leukemia - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology stock rises on leukemia drug data (KURA:NASDAQ) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Is The Options Market Predicting A Spike In Kura Oncology Stock? - Barchart.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combinatio - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Strong Results from KOMET-007 Trial of Ziftomenib in Newly Diagnosed AML Patients - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology reports positive data for AML treatment ziftomenib - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly ... - Enidnews.com

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Kura Oncology’s SWOT analysis: ziftomenib stock potential in AML treatment - Investing.com

Jun 12, 2025

Kura Oncology Inc (KURA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):